clodronic acid has been researched along with Malignant Melanoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, T; Hao, J; Liu, J; Tang, H; Wang, M; Wang, X; Wang, Y; Zhuang, Q | 1 |
| Connis, N; Freel Meyers, CL; Hann, CL; Kamat, C; Rudek, MA; Webster, MR; Weeraratna, AT; Zhao, M | 1 |
| Forsea, AM; Geilen, CC; Müller, C; Orfanos, CE; Riebeling, C | 1 |
| Conroy, M; Cree, IA; Fernando, A; Knight, LA; Kurbacher, CM; Polak, M | 1 |
4 other study(ies) available for clodronic acid and Malignant Melanoma
| Article | Year |
|---|---|
Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery.
Topics: Animals; Antineoplastic Agents; Biological Availability; Clodronic Acid; Drug Carriers; Lactic Acid; Liposomes; Liver; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Distribution | 2018 |
Bisphosphonamidate clodronate prodrug exhibits selective cytotoxic activity against melanoma cell lines.
Topics: Amides; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Cells, Cultured; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Inhibitory Concentration 50; Melanoma; Mice, Nude; Prodrugs; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
Topics: Antimetabolites; Antineoplastic Agents; Cell Cycle; Clodronic Acid; Diphosphonates; Disease Progression; Humans; Imidazoles; Melanoma; Nitrogen; Pamidronate; Skin Neoplasms; Tumor Cells, Cultured; Zoledronic Acid | 2004 |
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caspase 3; Caspase 7; Caspases; Cell Line, Tumor; Cell Survival; Cisplatin; Clodronic Acid; Diphosphonates; Energy Metabolism; Female; Humans; Imidazoles; Inhibitory Concentration 50; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured; Zoledronic Acid | 2005 |